Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and External Validation of a Multi-Institutional Model
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference46 articles.
1. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline;Videtic;Pract Radiat Oncol,2017
2. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy;Baumann;J Clin Oncol,2009
3. SBRT for early stage lung cancer: outcomes from biopsy-proven and empirically treated lesions;Wegner;Lung Cancer Manag,2018
4. Combining radiation plus immunotherapy to improve systemic immune response;Cushman;J Thorac Dis,2018
5. Combining stereotactic body radiation therapy with immunotherapy: current data and future directions;Lin;Transl Lung Cancer Res,2019
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insights;The Journal of Liquid Biopsy;2024-09
2. Prospective external validation of radiomics‐based predictive model of distant metastasis after dynamic tumor tracking stereotactic body radiation therapy in patients with non‐small‐cell lung cancer: A multi‐institutional analysis;Journal of Applied Clinical Medical Physics;2024-08-23
3. Development and Validation of a Prediction Model for Thyroid Dysfunction in Patients During Immunotherapy;Endocrine Practice;2024-07
4. Predicting Regional Recurrence and Prognosis in Stereotactic Body Radiation Therapy-Treated Clinical Stage I Non-small Cell Lung Cancer Using a Radiomics Model Constructed With Surgical Data;International Journal of Radiation Oncology*Biology*Physics;2024-06
5. Identification of CT radiomic features robust to acquisition and segmentation variations for improved prediction of radiotherapy-treated lung cancer patient recurrence;Scientific Reports;2024-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3